Amphetamine Completed Phase 3 Trials for Attention Deficit Disorder With Hyperactivity (ADHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00393042Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR
NCT00507065Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)